Cargando…
A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
BACKGROUND: Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1. CASE PRESENTATION: We report the clinical a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973878/ https://www.ncbi.nlm.nih.gov/pubmed/24589093 http://dx.doi.org/10.1186/1471-2369-15-41 |
_version_ | 1782479385913196544 |
---|---|
author | Santangelo, Luisa Gigante, Maddalena Netti, Giuseppe Stefano Diella, Sterpeta Puteo, Flora Carbone, Vincenza Grandaliano, Giuseppe Giordano, Mario Gesualdo, Loreto |
author_facet | Santangelo, Luisa Gigante, Maddalena Netti, Giuseppe Stefano Diella, Sterpeta Puteo, Flora Carbone, Vincenza Grandaliano, Giuseppe Giordano, Mario Gesualdo, Loreto |
author_sort | Santangelo, Luisa |
collection | PubMed |
description | BACKGROUND: Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1. CASE PRESENTATION: We report the clinical and genetic diagnosis of a 5-years old girl with SIOD, referred to our Center because of nephrotic-range proteinuria occasionally detected during the follow-up for congenital hypothyroidism. Mutational analysis of SMARCAL1 gene was performed by polymerase chain reaction (PCR) and bidirectional sequencing. Sequence analysis revealed that patient was compound heterozygous for two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p.Glu848*). CONCLUSION: This report provided the clinical and genetic description of a mild phenotype of Schimke immuno-osseous dysplasia associated with nephrotic proteinuria, decreasing after combined therapy with ACE inhibitors and sartans. Our experience highlighted the importance of detailed clinical evaluation, appropriate genetic counseling and molecular testing, to provide timely treatment and more accurate prognosis. |
format | Online Article Text |
id | pubmed-3973878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39738782014-04-04 A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) Santangelo, Luisa Gigante, Maddalena Netti, Giuseppe Stefano Diella, Sterpeta Puteo, Flora Carbone, Vincenza Grandaliano, Giuseppe Giordano, Mario Gesualdo, Loreto BMC Nephrol Case Report BACKGROUND: Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1. CASE PRESENTATION: We report the clinical and genetic diagnosis of a 5-years old girl with SIOD, referred to our Center because of nephrotic-range proteinuria occasionally detected during the follow-up for congenital hypothyroidism. Mutational analysis of SMARCAL1 gene was performed by polymerase chain reaction (PCR) and bidirectional sequencing. Sequence analysis revealed that patient was compound heterozygous for two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p.Glu848*). CONCLUSION: This report provided the clinical and genetic description of a mild phenotype of Schimke immuno-osseous dysplasia associated with nephrotic proteinuria, decreasing after combined therapy with ACE inhibitors and sartans. Our experience highlighted the importance of detailed clinical evaluation, appropriate genetic counseling and molecular testing, to provide timely treatment and more accurate prognosis. BioMed Central 2014-03-03 /pmc/articles/PMC3973878/ /pubmed/24589093 http://dx.doi.org/10.1186/1471-2369-15-41 Text en Copyright © 2014 Santangelo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Santangelo, Luisa Gigante, Maddalena Netti, Giuseppe Stefano Diella, Sterpeta Puteo, Flora Carbone, Vincenza Grandaliano, Giuseppe Giordano, Mario Gesualdo, Loreto A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) |
title | A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) |
title_full | A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) |
title_fullStr | A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) |
title_full_unstemmed | A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) |
title_short | A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) |
title_sort | novel smarcal1 mutation associated with a mild phenotype of schimke immuno-osseous dysplasia (siod) |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973878/ https://www.ncbi.nlm.nih.gov/pubmed/24589093 http://dx.doi.org/10.1186/1471-2369-15-41 |
work_keys_str_mv | AT santangeloluisa anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT gigantemaddalena anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT nettigiuseppestefano anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT diellasterpeta anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT puteoflora anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT carbonevincenza anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT grandalianogiuseppe anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT giordanomario anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT gesualdoloreto anovelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT santangeloluisa novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT gigantemaddalena novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT nettigiuseppestefano novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT diellasterpeta novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT puteoflora novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT carbonevincenza novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT grandalianogiuseppe novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT giordanomario novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod AT gesualdoloreto novelsmarcal1mutationassociatedwithamildphenotypeofschimkeimmunoosseousdysplasiasiod |